TI-CH, Updates on dostarlimab, ventoclax, & zongertinib Podcast Por arte de portada

TI-CH, Updates on dostarlimab, ventoclax, & zongertinib

TI-CH, Updates on dostarlimab, ventoclax, & zongertinib

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 This episode summarizes recent updates on: Tumor infiltrating clonal hematopoiesis (TI-CH) and its apparent negative impact on solid tumors (https://www.nejm.org/doi/full/10.1056/NEJMoa2413361) Updated dostarlimab data on MMRd use in rectal cancer and other solid tumors in the neoadjuvant (definitive?!?!) setting (https://www.nejm.org/doi/full/10.1056/NEJMoa2404512) Phase 1 study of 7 + 3 + Venetoclax (https://doi.org/10.1182/blood.2024026700) Zongertinib, a new HER2 TKI (https://www.nejm.org/doi/full/10.1056/NEJMoa2503704)
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones